Antioxidant Effects and in vitro Cytotoxicity on Human Cancer Cell Lines of Flavonoid-Rich Flamboyant (Delonix regia (Bojer) Raf.) Flower Extract
Related Experiment Video
Updated: Dec 3, 2025

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
Putthiporn Khongkaew1, Phanphen Wattanaarsakit2, Konstantinos I Papadopoulos3
1Faculty of Pharmaceutical Science, Burapha University, 169 Long-haad Bangsaen Road, Saensook, Mueng, Chonburi 20131, Thailand.
Background:
Cancer is a non-communicable disease with increasing incidence and mortality rates worldwide, including Thailand. Its apparent lack of effective treatments is posing challenging public health issues.
Introduction:
Encouraging research results indicating probable anti-cancer properties of the Delonix regia flower Extract (DRE) have prompted us to evaluate the feasibility of developing a type of product for future cancer prevention or treatment.
Methods And Results:
In the present report, using High-Performance Liquid Chromatography (HPLC), we demonstrate in the DRE the presence of high concentrations of three identifiable flavonoids, namely rutin 4.15±0.30% w/w, isoquercitrin 3.04±0.02 %w/w, and myricetin 2.61±0.01% w/w, respectively, while the IC50 of DPPH and ABTS assay antioxidation activity was 66.88±6.30 μg/ml and 53.65±7.24 μg/ml, respectively.
Discussion:
Our cancer cell line studies using the MTT assay demonstrated DREs potent and dosedependent inhibition of murine leukemia cell line (P-388: 35.28±4.07% of cell viability remaining), as well as of human breast adenocarcinoma (MCF-7), human cervical carcinoma (HeLa), human oral cavity carcinoma (KB), and human colon carcinoma (HT-29) cell lines in that order of magnitude.
Conclusion:
Three identifiable flavonoids (rutin, isoquercitrin and myricetin) with high antioxidation activity and potent and dose-dependent inhibition of murine leukemia cell line and five other cancer cell lines were documented in the DRE. The extract's lack of cytotoxicity in 3 normal cell lines is a rare advantage not usually seen in current antineoplastic agents. Yet another challenge of the DRE was its low dissolution rate and long-term storage stability, issues to be resolved before a future product can be formulated.
Insights
Delonix regia flower Extract (DRE) contains flavonoids with potent anti-cancer properties, effectively inhibiting multiple cancer cell lines. This natural extract shows promise for cancer prevention and treatment, with minimal toxicity to normal cells.
Area of Science:
- Phytochemistry
- Pharmacology
- Cancer Research
Background:
- Cancer presents a significant global health challenge with increasing incidence and mortality.
- Effective cancer treatments remain limited, necessitating research into novel therapeutic agents.
- The Delonix regia flower Extract (DRE) has shown potential anti-cancer properties, warranting further investigation.
Purpose of the Study:
- To evaluate the anti-cancer potential of Delonix regia flower Extract (DRE).
- To identify key bioactive compounds within the DRE.
- To assess the efficacy and safety of DRE against various cancer cell lines.
Main Methods:
- High-Performance Liquid Chromatography (HPLC) was used to identify and quantify flavonoids in DRE.
- Antioxidant activity was assessed using DPPH and ABTS assays.
- Cytotoxicity and anti-proliferative effects were evaluated using the MTT assay on multiple cancer and normal cell lines.
Main Results:
- DRE contains high concentrations of rutin (4.15±0.30% w/w), isoquercitrin (3.04±0.02% w/w), and myricetin (2.61±0.01% w/w).
- The extract exhibited significant antioxidant activity with IC50 values of 66.88±6.30 μg/ml (DPPH) and 53.65±7.24 μg/ml (ABTS).
- DRE demonstrated potent, dose-dependent inhibition of cancer cell lines, including P-388, MCF-7, HeLa, KB, and HT-29, with minimal cytotoxicity to normal cell lines.
Conclusions:
- DRE is rich in bioactive flavonoids with strong antioxidant and anti-cancer properties.
- The extract effectively inhibits the proliferation of various cancer cell lines.
- DRE presents a promising natural agent for cancer prevention and treatment, though formulation challenges like dissolution rate and stability require further research.

